Preventive Healthcare Technologies And Services Market Size, Share & Trends Analysis Report By Type (Early Detection & Screening, Chronic Disease Management, Vaccines), By Region, And Segment Forecasts, 2023 - 2030

Preventive Healthcare Technologies And Services Market Size & Trends

The global preventive healthcare technologies and services market size was valued at USD 243.0 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 11.8% from 2023 to 2030. The growth of this market is attributed to the increasing prevalence of lifestyle-associated and other chronic diseases. According to a report by the National Institute of Health (NIH), 35.66 percent of the U.S. adult population aged 50 and over will have at least one chronic condition by 2035.

Preventive healthcare has been gaining popularity in the past decade, with the growing number of awareness programs by the government. The Patient Protection and Affordable Care Act, or Obamacare, has mandated the inclusion of preventive healthcare by insurance providers at no added cost. The private insurance companies have also started shifting their focus on this market due to its huge potential.

From the customers’ perspective, preventive healthcare gives people a better-quality and stress-free life. The investment in these insurance policies or the average spending on these services is far less than the average spending on treating any disease in the hospital. Along with affordability, the easy availability of diagnostic devices capable of early detection of asymptomatic diseases is expected to fuel growth during the forecast period. According to Statista, more than 300 billion individuals in the U.S. had some form of health insurance coverage in 2021, compared to 257 billion people in 2010.

Though the target population of these services and technologies includes everyone from all age groups, a major part includes geriatrics, which are more prone to chronic conditions and acute cardiovascular diseases. The geriatric population is on the rise and is expected to grow throughout the forecast period, which is anticipated to impact growth positively. According to World Health Organization (WHO), the population aged 60 and over is expected to double between 2020 and 2050, reaching 2.1 billion by 2050. Meanwhile, the number of people aged 80 and over is projected to reach 426 billion by 2050.

COVID-19 has been a major threat to countries in recent times. Screening is essential to prevent future health issues or to catch them earlier when they are more treatable. According to a study of the estimated impact of preventive care service delivery published in October 2021, COVID-19 significantly reduced the provision of preventative care services, which may lead to delayed diagnoses, higher mortality, and higher health care costs. COVID-19 impacted the market significantly. However, with the development of virtual care, the rise in vaccination campaigns, and the re-opening of screening centers, the demand for preventive health technologies and services is expected to remain at pre-pandemic levels, indicating healthy growth in the forecast period.

Type Insights

Based on type, the market is segmented into early detection and screening technologies, chronic disease management technologies, vaccines, and advanced technologies to reduce errors. The early detection and screening technologies segment dominated the market with the largest revenue share in 2022. The advantages associated with personalized medicine technologies, such as high accuracy and detection of possible disease or disorder at an early stage, are mainly attributed to the largest share of the segment.

The chronic diseases segment is expected to grow at a lucrative CAGR over the forecast period owing to user-friendly devices such as blood pressure monitors, glucose monitors, and asthma monitors, which can be used without the help of any professionals or any training.

The vaccines segment held a significant share in 2022. Vaccination is the best prophylactic measure as it enables the development of antibodies by the body itself and does not require any screening to detect a particular disease. Vaccines against Influenza, COVID-19, and Bacteria (Tetanus, Diphtheria, Pertussis) exist. The demand for vaccines will continue to grow as R&D activities increase and new vaccination campaigns are launched to speed up the vaccination process. This will further expand the global preventive healthcare technologies and services market. Ongoing clinical trials for the vaccines designed to slow or cease degenerative disorders, such as Parkinson’s and Alzheimer’s, have been witnessing positive results.

Regional Insights

North America dominated the market with the largest revenue share of 40.4% in 2022. The presence of well-established healthcare infrastructure, the higher adoption rate of advanced technology, the increase in the incidence of chronic disease, and the high awareness regarding preventive healthcare measures are the factors attributed to the region's domination. For instance, according to a report by the Centers for Disease Control and Prevention in May 2022, sixty percent of adults in the U.S. have a chronic illness, and forty percent of adults have two chronic conditions or more. Moreover, the launch of new technologies in the region is expected to boost the market further; for instance, in February 2022, Teladoc Health announced the launch of Chronic Care Complete as the world’s first comprehensive chronic condition management solution for improving health outcomes while managing multiple chronic conditions.

Asia Pacific region is expected to grow at the fastest CAGR of 14.2% over the forecast period, owing to increased government initiatives, adoption of advanced technologies, rising per capita income, and the presence of a large number of players engaged in the development of advanced technology for preventive healthcare in countries such as Japan and India is expected to boost the growth of the market in the region. The presence of major companies, such as Serum Institute of India Private Limited and Biocon, has increased the entry barrier for new entrants in the region.

Key Companies & Market Share Insights

The overall market is consolidated, with a few key players capturing most of the revenue. Early detection and screening technology are dominated by companies such as; Novx Systems, Inc.; and Dilon Technologies, Inc. Major vaccine segment players include Merck & Co. Inc.; Pfizer, Inc.; and GlaxoSmithKline plc. For instance, in October 2022, a vaccine candidate developed by GSK plc. for older adults with Respiratory Hypertension (RSV) demonstrated a 94.1% decrease in Severe RSV Disease and an overall vaccine efficacy rate of 82.6 percent in a pivotal trial.

In addition, in February 2023, Moderna, Inc. announced positive interim phase 3 trial results for the mRNA-1010 influenza flu vaccine. The results show the safety and immunogenicity of the vaccine in adults 18 years and older in the southern hemisphere. Some prominent players in the global preventive healthcare technologies and services market include:

• Myriad Genetics, Inc.

• Quest Diagnostics Incorporated

• Medtronic

• Abbott

• Merck & Co., Inc.

• GSK plc

• Omnicell

• MCKESSON CORPORATION

Preventive Healthcare Technologies And Services Market Report Scope 

Global Preventive Healthcare Technologies And Services Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For the purpose of this study, Grand View Research has segmented the global preventive healthcare technologies and servicesmarket on the basis of type and region:

• Type Outlook (Revenue in USD Billion, 2018 - 2030)

  • Early Detection & Screening Technologies

    • Automated Screening Market

    • Personalized Medicine Market

    • Other Advanced Screening Technologies

  • Chronic Disease Management Technologies

    • Blood Pressure Monitors

    • Asthma Monitors

    • Cardiovascular Monitors

    • Glucose Monitors

  • Vaccines

    • Infectious Diseases

    • Cancer

    • Autism

    • Allergy

    • Others

  • Advanced Technologies to Reduce Errors

    • Electronic Prescribing

    • Clinical Decision Support System

    • Smart Infusion Pumps

    • Computerized Provider Order Entry System

    • Smart Packaging

    • Automated Prescription Formulation & Dispensing

• Regional Outlook (Revenue in USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • Thailand

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait